Active substances
Desogestrel + Ethinylestradiol
- SFDA 7
- US FDA 34
- Health Canada 12
- US price lines 8
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CYBELLE FILM COATED TABLET | 30,150 µg,µg | Film-coated tablet · Oral use | 28 Blister | SAR 10.20 | Generic · Prescription | Exeltis Healthcare S.L | Valid |
| GRACIAL TABLET | 0.025,0.03 mg,mg | Tablet · Oral use | 22 Blister | SAR 19.60 | Generic · Prescription | ASPEN PHARMA TRADING LIMITED (APTL) | Valid |
| MARVELON TAB | 150,30 µg,µg | Tablet · Oral use | 21 Blister | SAR 14.60 | Generic · Prescription | ORGANON | Valid |
| REGULON | 150,30 µg,µg | Film-coated tablet · Oral use | 21 Blister | SAR 10.20 | Generic · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Valid |
| GRACIAL TABLET | 0.03, 0.025 mg | Tablet · Oral use | 22 Blister | SAR 21.85 | Generic · Prescription | ORGANON | Withdrawn by MAH · Not Marketed |
| MARVELON TAB | 30, 150 µg | Tablet · Oral use | 63 Blister | SAR 32.65 | Generic · Prescription | ORGANON | Withdrawn by MAH · Not Marketed |
| REGULON | 30, 150 µg | Film-coated tablet · Oral use | 63 Blister | SAR 22.85 | Generic · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
CONTRACEPTION; ENDOMETRIOSIS; HYPERPROLACTINEMIA; MENOPAUSE; MENSTRUAL DISORDERS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DESOGESTREL AND ETHINYL ESTRADIOL | 0.15MG;0.03MG | tablet · oral-28 | DURAMED PHARMS BARR | Prescription | 12 Aug 1999 |
| CYCLESSA | 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG | tablet · oral-28 | ASPEN GLOBAL INC | Prescription | 20 Dec 2000 |
| KARIVA | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | BARR | Prescription | 5 Apr 2002 |
| VELIVET | 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG | tablet · oral-28 | DURAMED PHARMS BARR | Prescription | 24 Feb 2004 |
| DESOGESTREL; ETHINYL | 0.125MG/0.025MG; 0.15MG/0.025MG | tablet · oral | DURAMED PHARMS BARR | Prescription | 24 Feb 2004 |
| DESOGESTREL AND ETHINYL ESTRADIOL | 0.15MG;0.03MG | tablet · oral-28 | WATSON LABS | Prescription | 29 Jul 2005 |
| DESOGESTREL; ETHINYL ESTRADIOL | 0.125MG/0.025MG; 0.15MG/0.025MG | tablet · oral-28 | DR REDDYS LABS SA | Prescription | 24 Jan 2006 |
| VIORELE | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | GLENMARK PHARMS LTD | Prescription | 2 Apr 2012 |
| ENSKYCE | 0.15MG;0.03MG | tablet · oral-28 | LUPIN LTD | Prescription | 7 Mar 2013 |
| DESOGESTREL AND ETHINYL ESTRADIOL | 0.15MG;0.03MG | tablet · oral-28 | NOVAST LABS | Prescription | 12 Jul 2013 |
| PIMTREA | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | NOVAST LABS | Prescription | 1 Aug 2013 |
| DESOGESTREL AND ETHINYL ESTRADIOL | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | XIROMED | Prescription | 30 Aug 2013 |
| BEKYREE | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | LUPIN | Prescription | 12 Aug 2015 |
| ISIBLOOM | 0.15MG;0.03MG | tablet · oral-28 | XIROMED | Prescription | 12 Aug 2015 |
| VOLNEA | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | XIROMED | Prescription | 9 Sep 2016 |
| SIMLIYA | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | AUROBINDO PHARMA | Prescription | 22 Mar 2017 |
| KALLIGA | 0.15MG;0.03MG | tablet · oral-28 | AUROBINDO PHARMA | Prescription | 17 May 2017 |
| DESOGESTREL AND ETHINYL ESTRADIOL | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | NAARI PTE | Prescription | 5 Jun 2017 |
| DESOGESTREL AND ETHINYL ESTRADIOL | 0.15MG;0.03MG | tablet · oral-28 | NAARI PTE | Prescription | 13 Sep 2018 |
| AVERI | 0.15MG;0.03MG | tablet · oral-21 | AVION PHARMS | Prescription | 2 May 2025 |
| AVERI | 0.15MG;0.03MG | tablet · oral-28 | AVION PHARMS | Prescription | 2 May 2025 |
| DESOGESTREL AND ETHINYL ESTRADIOL | 0.15MG;0.03MG | tablet · oral-28 | ANNORA PHARMA | Prescription | 18 Mar 2026 |
| DESOGESTREL AND ETHINYL ESTRADIOL | 0.15MG,N/A;0.02MG,0.01MG | tablet · oral-28 | ANNORA PHARMA | Prescription | 7 Jul 2026 |
| DESOGEN | 0.15MG;0.03MG | tablet · oral-21 | ORGANON USA INC | Discontinued | 10 Dec 1992 |
| DESOGEN | 0.15MG;0.03MG | tablet · oral-28 | ORGANON USA INC | Discontinued | 10 Dec 1992 |
9 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APRI 21 | 02317192 | 0.15 MG; 0.03 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| APRI 28 | 02317206 | 0.03 MG; 0.15 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| FREYA 21 | 02396491 | 0.15 MG; 0.03 MG | TABLET · ORAL | SENADOR LABORATORIES PRIVATE LIMITED |
| FREYA 28 | 02396610 | 0.03 MG; 0.15 MG | TABLET · ORAL | SENADOR LABORATORIES PRIVATE LIMITED |
| LINESSA 21 | 02272903 | 0.025 MG; 0.15 MG; 0.125 MG; 0.1 MG | TABLET · ORAL | ASPEN PHARMACARE CANADA INC. |
| LINESSA 28 | 02257238 | 0.1 MG; 0.025 MG; 0.125 MG; 0.15 MG | TABLET · ORAL | ASPEN PHARMACARE CANADA INC. |
| MARVELON 21 | 02042487 | 0.15 MG; 0.03 MG | TABLET · ORAL | ORGANON CANADA INC. |
| MARVELON 28 | 02042479 | 0.15 MG; 0.03 MG | TABLET · ORAL | ORGANON CANADA INC. |
| MILEY 21 | 02556553 | 0.15 MG; 0.03 MG | TABLET · ORAL | AMBICARE PHARMACEUTICALS INC. |
| MILEY 28 | 02556561 | 0.03 MG; 0.15 MG | TABLET · ORAL | AMBICARE PHARMACEUTICALS INC. |
| MIRVALA 21 | 02410249 | 0.1500 MG / TAB; 0.0300 MG / TAB | TABLET · ORAL | APOTEX INC |
| MIRVALA 28 | 02410257 | 0.1500 MG / TAB; 0.0300 MG / TAB | TABLET · ORAL | APOTEX INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ENSKYCE 28 TABLET | $0.13531 | per EA | 23 Sep 2026 |
| US NADAC | ISIBLOOM 28 DAY TABLET | $0.13531 | per EA | 23 Sep 2026 |
| US NADAC | KARIVA 28 DAY TABLET | $0.17245 | per EA | 23 Sep 2026 |
| US NADAC | PIMTREA 28 DAY TABLET | $0.17245 | per EA | 23 Sep 2026 |
| US NADAC | SIMLIYA 28 DAY TABLET | $0.17245 | per EA | 23 Sep 2026 |
| US NADAC | VELIVET 28 DAY TABLET | $0.53646 | per EA | 23 Sep 2026 |
| US NADAC | VIORELE 28 DAY TABLET | $0.17245 | per EA | 23 Sep 2026 |
| US NADAC | VOLNEA 0.15-0.02-0.01 MG TAB | $0.17245 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Ethinylestradiol 20microgram / Desogestrel 150microgram tablets | £5.98 | 63 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ethinylestradiol 30microgram / Desogestrel 150microgram tablets | £4.93 | 63 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.